Synairgen’s inhaled COVID-19 treatment included in US trial by Lucy Parsons | Feb 10, 2021 | News | 0 Trial is sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID) Read More
Synairgen begins large-scale trial of inhaled COVID-19 treatment by Lucy Parsons | Jan 13, 2021 | News | 0 First patient in global trial dosed in the UK Read More
Synairgen’s SNG001 shows strong promise in COVID-19 trial by Selina McKee | Jul 20, 2020 | News | 0 The drug significantly cut the risk of developing severe disease and patients were twice as likely to recover versus placebo Read More